Giuseppe Esposito MD MBA

Professor, Radiology, Georgetown University School of Medicine

3800 Reservoir Rd NW2005 Gorman BldgWashington, DC 20007
Phone+1 202-444-3450
Fax+1 202-444-4667

Dr. Esposito is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Esposito's full profile Already have an account?

Summary

Dr. Giuseppe Esposito is a nuclear medicine specialist based in Washington, DC, with extensive experience in nuclear cardiology, positron emission tomography, central nervous system nuclear procedures, oncologic nuclear procedures, and oncology. Dr. Esposito completed a residency in internal medicine at MedStar Franklin Square Medical Center and a residency in nuclear medicine at Johns Hopkins University, having graduated from the University of Naples Faculty of Medicine in 1990. Additionally, Dr. Esposito holds an MBA in Medical Services Management from Johns Hopkins Carey Business School. Dr. Esposito has contributed to several publications, including work on brain PET/CT imaging in dementia and outcomes in patients with dementia with Lewy bodies. Active in clinical research, Dr. Esposito has participated in trials focusing on advanced prostate cancer and chemotherapy response in lung cancer, and was recognized as a Top Doctor in the Washington DC area by Castle Connolly in 2024.

Education & Training

Johns Hopkins Carey Business SchoolMBA, Medical Services Management, 2012 - 2015
MedStar Franklin Square Medical CenterResidency, Internal Medicine, 2000 - 2001
Johns Hopkins UniversityResidency, Nuclear Medicine, 1998 - 2000
University of Naples Faculty of MedicineClass of 1990

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MD State Medical License 2001 - 2028
WI State Medical License 2023 - 2027
DC State Medical License 2003 - 2026
VA State Medical License 2025 - 2026
NY State Medical License 2004 - 2009
American Board of Nuclear Medicine Nuclear Medicine

Awards, Honors, & Recognition

Top Doctors:Washington DC Area - Nuclear Medicine Castle Connolly, 2024

Clinical Trials

A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC
COMPLETED
PHASE2
I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW). Start of enrollment: 2019 May 30
COMPLETED
PHASE2

Publications & Presentations

PubMed

1 citations
131I-LNTH-1095 Radioligand Therapy plus Enzalutamide versus Enzalutamide Alone in Men with PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase II Study.
Evan Y Yu, Vivek Narayan, Giuseppe Esposito, Russell Szmulewitz, Yang Lu
Clinical Cancer Research. 2026-05-15
CD8 PET imaging with [Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study.
Michael A Postow, Peter D Zang, Sumanta K Pal, Audrey Mauguen, Michael Farwell
Journal for Immunotherapy of Cancer. 2026-03-27
ACR-ACNM-ASNR-SNMMI Practice Parameter for the Performance of Brain PET/CT Imaging in Dementia.
Raymond K Tu, Giuseppe Esposito, Amit Agarwal, Esma A Akin, Ciprian Catana
AJNR. American Journal of Neuroradiology. 2026-02-03

Lectures

Lack of Prognostic Significance of Pre-Treatment Total Metabolic Tumor Volume (TMTV) in Diffuse Large B-Cell Lymphoma (DLBCL)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

SNMMI Unveils 2026 Image of the YearJune 3rd, 2026
First Diagnosed Case of Alzheimer’s Disease in HIV-Positive Individual ReportedJuly 25th, 2016
SNMMI: PET Tracer That Detects Deep Vein Thrombosis Wins Image of the YearJune 2nd, 2026